QbD
Designing Quality into Biomanufacturing
Miguel Carrion; Michelle Kneeland
Tanvex CDMO
PAO-10-24-CL-09Oct 29, 2024
Advanced Therapies
A New Vision for Progressing Advanced Therapies
Nathaniel Youndt
ReciBioPharm
PAO-10-24-CL-13Oct 25, 2024
Financing
Samsung Biologics reports third quarter 2024 financial results
Samsung Biologics
PR-10-24-NI-58Oct 23, 2024
CDMO
Mikart Adds Nitrogen-Purged Capability to Liquid and Suspension Suites
Mikart
PR-10-24-NI-54Oct 22, 2024
Lyophilization
Pioneering Innovation in Pharmaceutical Lyophilization
Thermo Fisher Scientific
PAO-10-24-CL-05Oct 22, 2024
Appointment
Bio X Cell Announces Board of Director Appointments
Bio X Cell
PR-10-24-NI-45Oct 17, 2024
CDMO
Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development
Samsung Biologics
PR-10-24-NI-41Oct 14, 2024
CDMO
Revolutionary CDMO Wheeler Bio Appoints Patrick Lucy as CEO
David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-24-CL-08Oct 11, 2024
Announcement
Genezen Appoints Mike Wourms as Chief Operations Officer
Genezen
PR-10-24-NI-36Oct 08, 2024
CDMO
Innovating and Collaborating to Support Biopharma Beyond the Typical CDMO
Janet Hoogstraate, Ph.D.
NorthX Biologics
PAO-10-24-CL-07Oct 07, 2024
RNA
Optimized Residual dsRNA Detection for mRNA Therapeutics
Eunseo (Ency) Lee, Ph.D; Namhyun Kim; Hwanjun Yoon, Ph.D.; Sukhwan Kim; Ahyeon Hwang
Samsung Biologics
PAO-09-24-CL-07Sep 30, 2024
Bioassays
Developing a Toolbox of Functional Bioassays for Optimizing ADCC
Anke Hartung, Ph.D.,
Tanvex CDMO
PAO-09-24-CL-09Sep 30, 2024
Financing
CPhI WW, Olon Will Attend with a Stronger Market Position after the Two International Acquisitions
Olon
PR-09-24-NI-23Sep 30, 2024
Biopharma
AbZelectPRO™ enables biopharma customers to reach their research cell bank in 10 weeks with 8g/L
Abzena
PR-09-24-NI-18Sep 26, 2024
CDMO
SK pharmteco and Cryoport Partner for Cell and Gene Therapy Logistics and BioServices
Cryoport
PR-09-24-NI-16Sep 26, 2024
CDMO
PCI Invests Over $365 Million in Facilities for Supply of Advanced Drug Delivery and Drug-Device Combination Products
PCI Pharma Services
PR-09-24-NI-15Sep 24, 2024
CDMO
Wheeler Bio Licenses ATUM’s miFuc Technology to Expand Their Portable CMC Platform Capabilities
Wheeler Bio
PR-09-24-NI-14Sep 24, 2024
CDMO
FDA Approves First Treatment for Niemann-Pick Disease, Type C
U.S. Food & Drug Administration
PR-09-24-NI-12Sep 23, 2024
CDMO
UCB Announces FDA Approvals for BIMZELX for Psoriatic Arthritis, Axial Spondyloarthritis, and Ankylosing Spondylitis
UCB
PR-09-24-NI-13Sep 23, 2024
Commercialization
Development Strategies for Overcoming Commercialization Challenges
Matthias Lucke, Ph.D.
Coriolis Pharma
PAO-09-24-CL-10Sep 17, 2024